Compare
NAVs as of 20 Aug 2026
Growth of ₹100 (rebased over the selected window)
Common period 18 Apr 2023 – 20 Aug 2026, limited by Kotak Nifty Smallcap 50 Index Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | ICICI Prudential Nifty Pharma Index Fund | ICICI Prudential NASDAQ 100 Index Fund | ICICI Prudential Nifty Auto Index Fund | Kotak Nifty Smallcap 50 Index Fund | Nifty 500 | Nasdaq 100 | Nifty Smallcap 250 |
|---|---|---|---|---|---|---|---|
| 18 Apr 2023 | ₹100.00 | ₹100.00 | ₹100.00 | ₹100.00 | ₹100.00 | ₹100.00 | ₹100.00 |
| 29 Jul 2023 | ₹118.16 | ₹120.56 | ₹119.34 | ₹120.02 | ₹113.77 | ₹120.31 | ₹123.19 |
| 07 Nov 2023 | ₹119.99 | ₹118.39 | ₹124.17 | ₹140.23 | ₹115.38 | ₹116.84 | ₹136.53 |
| 17 Feb 2024 | ₹147.98 | ₹136.35 | ₹156.54 | ₹171.92 | ₹135.36 | ₹135.09 | ₹165.50 |
| 29 May 2024 | ₹150.95 | ₹144.83 | ₹181.46 | ₹177.03 | ₹142.69 | ₹143.12 | ₹173.03 |
| 07 Sep 2024 | ₹179.92 | ₹143.33 | ₹195.77 | ₹208.73 | ₹157.60 | ₹140.71 | ₹200.67 |
| 18 Dec 2024 | ₹173.57 | ₹166.80 | ₹177.89 | ₹208.44 | ₹153.95 | ₹162.00 | ₹198.60 |
| 30 Mar 2025 | ₹164.46 | ₹152.99 | ₹162.64 | ₹174.44 | ₹143.25 | ₹147.28 | ₹165.55 |
| 09 Jul 2025 | ₹172.69 | ₹181.61 | ₹183.06 | ₹207.21 | ₹158.14 | ₹174.65 | ₹194.91 |
| 19 Oct 2025 | ₹172.96 | ₹201.38 | ₹208.46 | ₹196.20 | ₹158.41 | ₹189.57 | ₹187.17 |
| 29 Jan 2026 | ₹167.13 | ₹219.35 | ₹202.75 | ₹183.94 | ₹155.30 | ₹197.71 | ₹171.32 |
| 10 May 2026 | ₹186.65 | ₹254.04 | ₹208.05 | ₹205.48 | ₹155.17 | ₹223.31 | ₹191.13 |
| 20 Aug 2026 | ₹204.52 | ₹256.61 | ₹224.86 | ₹222.12 | ₹157.84 | ₹223.29 | ₹201.01 |
Portfolio overlap (same stocks held through more than one fund)
Some overlap is structural: SEBI defines large cap as the top 100 stocks by market capitalisation, so two large-cap funds are fishing the same pond by regulation. The bands below are measured per sleeve pairing rather than against one blanket threshold. How this is measured →
| Overlap | ICICI Prudential Nifty Pharma Index Fund | ICICI Prudential Nifty Auto Index Fund | Kotak Nifty Smallcap 50 Index Fund |
|---|---|---|---|
| ICICI Prudential Nifty Pharma Index Fund | |||
| ICICI Prudential Nifty Auto Index Fund | |||
| Kotak Nifty Smallcap 50 Index Fund |
ICICI Prudential Nifty Pharma Index Fund and Kotak Nifty Smallcap 50 Index Fund share 5% of their equity book by weight.
Shared holdings — ICICI Prudential Nifty Pharma Index Fund vs Kotak Nifty Smallcap 50 Index Fund
| Stock | ICICI Prudential Nifty Pharma Index Fund | Kotak Nifty Smallcap 50 Index Fund | |
|---|---|---|---|
| Gland Pharma Ltd | 2.15% | 2.62% | 2.15% |
| Wockhardt Ltd | 1.73% | 2.11% | 1.73% |
| Piramal Pharma Ltd | 1.13% | 1.38% | 1.13% |
3 shared of 20 / 50 positions. Weights are shown as a share of each fund's equity book.
No published holdings for ICICI Prudential NASDAQ 100 Index Fund — left out entirely rather than counted as 0% overlap.
| Metric | ICICI Prudential · Regular · IDCW NAV ₹19.99 Very High risk ★★★★★ | ICICI Prudential · Regular · IDCW NAV ₹23.75 Very High risk ★★★★☆ | ICICI Prudential · Regular · IDCW NAV ₹23.21 Very High risk ★★★★☆ | Kotak Mahindra · Regular · IDCW NAV ₹22.68 Very High risk ★★★★☆ | Category median Index Funds · 271 funds |
|---|---|---|---|---|---|
| +19.53% | +37.18%Best in row | +15.20% | +13.23% | +4.72% | |
| +19.28% | +31.12%Best in row | +23.77% | +22.14% | +7.52% | |
| +20.90% | +19.42% | +24.18% | +26.99%Best in row | +7.27% | |
| +19.51% | +28.65%Best in row | +21.17% | +16.88% | — | |
| +21.61% | +25.79% | +25.69% | +23.20% | +7.88% | |
| Risk | |||||
| 15.02%Best in row | 21.33% | 19.23% | 20.52% | 13.54% | |
| 0.85 | 1.15Best in row | 0.90 | 0.76 | 0.11 | |
| 1.23 | 1.71Best in row | 1.30 | 1.03 | 0.15 | |
| -16.78%Best in row | -30.21% | -28.51% | -25.11% | -15.67% | |
| Nifty 500 | Nasdaq 100 | Nifty 500 | Nifty Smallcap 250 | — | |
| +9.21% | +4.64% | +10.32%Best in row | +3.89% | -0.05% | |
| 0.67 | 0.99 | 1.08 | 1.01 | 1.00 | |
| 106.4% | 108.9% | 139.5%Best in row | 110.5% | 101.3% | |
| 62.5%Best in row | 90.5% | 100.2% | 99.1% | 99.5% | |
| 1.19% | 1.06% | 0.95% | 0.93% | 0.88% | |
| ₹121.63Cr | ₹3,348Cr | ₹216.49Cr | ₹201.40Cr | ₹181.49Cr | |
| None | — | None | None | — | |
| ₹1.00K | ₹100 | ₹1.00K | ₹100 | — | |
| ₹1.00K | ₹1.00K | ₹1.00K | ₹100 | — | |
| 26% | 16% | 26% | 79% | 38% | |
| Ashwini Shinde | Sharmila D'silva | Ashwini Bharucha | Abhishek Bisen | — | |
| 15 Dec 2022 | 19 Oct 2021 | 12 Oct 2022 | 18 Apr 2023 | — | |
| 20 | — | 15 | 50 | — | |
| 78.0% | — | 88.7% | 31.7% | — | |
| 0.1% | 0.1% | 0.1% | -0.2% | — | |
5 rows carry the same value for every fund — show
- 5Y return (CAGR)
- —
- 10Y return (CAGR)
- —
- 5Y rolling avg
- —
- 10Y rolling avg
- —
- Lock-in
- None
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.